Forming growth factor-beta by cultured human mesangial cells. Nephrol Dial Transplant

Forming growth factor-beta by cultured human mesangial cells. Nephrol Dial Transplant 1997, 12:438?42. 30. Shirato K, Osawa H, Kaizuka M, Nakamura N, 3-Bromo-5-chloro-2-fluoroaniline Sugawara T, Nakamura M, Tamura M, Yamabe H, Okumura K: Thrombin stimulates production of fibronectin by human proximal tubular epithelial cells via a transforming growth factor-beta-dependent mechanism. Nephrol Dial Transplant 2003, 18:2248?254. 31. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W: Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002, 30:215?22. 32. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM: Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000, 18:307?16. 33. Jin JD, Wang HX, Xiao FJ, Wang JS, Lou X, Hu LD, Wang LS, Guo ZK: A novel rich source of human mesenchymal stem cells from the debris of bone marrow samples. Biochem Biophys Res Commun 2008, 376:191?95. 34. Han Y, Englert JA, Yang R, Delude RL, Fink MP: Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. J Pharmacol Exp Ther 2005, 312:1097?105. 35. Lee JS, Ha L, Park JH, Lim JY: Mechanical stretch suppresses BMP4 induction of stem cell adipogenesis via upregulating ERK but not through downregulating Smad or p38. Biochem Biophys Res Commun 2012, 418:278?83. 36. Dudley DT, Pang L, Decker SJ, Bridges AJ, peerj.2721 Saltiel AR: A synthetic inhibitor of the mitogen-activated PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12711626 protein kinase cascade. Proc Natl Acad Sci U S A 1995, 92:7686?689. 37. Ahn HS, Foster C, Boykow G, Stamford A, Manna M, Graziano M: Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl) phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (Sch 79797), a nonpeptide thrombin receptor antagonist. Biochem Pharmacol 2000, 60:1425?434. 38. Di Serio C, Pellerito S, Duarte M, Massi D, Naldini A, Cirino G, Prudovsky PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/9547713 I, Santucci M, Geppetti P, Marchionni N, Masotti G, Tarantini F: Proteaseactivated receptor 1-selective antagonist SCH79797 inhibits cell proliferation and induces apoptosis by a protease-activated receptor 1-independent mechanism. Basic Clin Pharmacol Toxicol 2007, 101:63?9. 39. El Eter EA, Aldrees A: Inhibition of proinflammatory cytokines by SCH79797, a selective protease-activated receptor 1 antagonist, protects rat kidney against ischemia-reperfusion injury. Shock 2012, 37:639?44. 40. McLarty JL, Melendez GC, Brower GL, Janicki JS, Levick SP: Tryptase/ Protease-activated receptor 2 interactions induce selective mitogenactivated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 2011, 58:264?70. 41. Chen Y, Yang C, Wang ZJ: Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin tert-Butyl (7-bromoheptyl)carbamate 1 in paclitaxelinduced neuropathic pain. Neuroscience 2011, 193:440?51. 42. Andoh T, Takayama Y, Yamakoshi T, Lee JB, Sano A, Shimizu T, Kuraishi Y: Involvement of serine protease and proteinase-activated receptor 2 in dermatophyte-associated itch in mice. J Pharmacol Exp Ther 2012, 343:91?6. 43. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal.

Leave a Comment